<?xml version="1.0" encoding="UTF-8"?>
<p>Compound 
 <bold>293</bold> was tested for antimicrobial activity against selected pathogens namely 
 <italic>S. aureus</italic>, 
 <italic>E. coli</italic> and 
 <italic>Pseudomonas aeruginosa</italic> C. Gessard. Funiculosone (
 <bold>293</bold>) displayed antimicrobial activity inhibiting the bacterial pathogens. Funiculosone was able to inhibit the growth of 
 <italic>E. coli</italic>, 
 <italic>S. aureus</italic> and 
 <italic>C. albicans</italic> with IC
 <sub>50</sub> of 25 μg/mL and 58 μg/mL and 35 μg/mL respectively [
 <xref rid="B95-ijms-22-00959" ref-type="bibr">95</xref>].
</p>
